Hong-Jie Jhou

31PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsEpidemiological methodsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 16, 2026
Effect of Remdesivir on Mortality in Mechanically Ventilated COVID-19 Patients: A Target Trial Emulation Using Inverse Probability of Treatment Weighting.

|Jun 11, 2026
Target Trial Emulation of Second-Generation Versus First-Generation Tyrosine Kinase Inhibitors in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

|May 06, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

|Jan 26, 2026
Contrast-Associated Acute Kidney Injury After Endovascular Therapy for Acute Ischemic Stroke: A Meta-Analysis.

Hong-Jie Jhou, Po-Huang Chen, Li-Yu Yang

|Dec 11, 2025
Correction: Chen et al. The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis. Diagnostics 2024, 14, 1030.

Yu-Han Chen, Lindsay Fogel, Andrea Yue-En Sun

|Dec 09, 2025
Osimertinib Versus First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Target Trial Emulation Study of Real-World Survival and Safety Outcomes.

Ren-Hua Ye, Hong-Jie Jhou, Hsin-Yu Chen

Pageof 6

Frequent Collaborators

24 joint publications

Po-Huang Chen

14 joint publications

Cho-Hao Lee

3 joint publications

Wei-Cheng Chang

3 joint publications

Ming-Shen Dai